Literature DB >> 21989716

Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet.

Adriano M de Assis1, Anderson Rech, Aline Longoni, Liane N Rotta, Cristiane C Denardin, Matheus A Pasquali, Diogo O Souza, Marcos L S Perry, José C Moreira.   

Abstract

Ω3-Polyunsaturated fatty acids (Ω3-PUFAs) are known to act as hypolipidaemics, but the literature is unclear about the effects that Ω3-PUFAs have on oxidative stress in obese and diabetic patients. In this study, our aim was to investigate the effects of Ω3-PUFAs on oxidative stress, including antioxidant enzyme activity and hepatic lipid and glycogen metabolism in the livers of diabetic and non-diabetic rats fed on a high fat thermolyzed diet. Rats were divided into six groups: (1) the control group (C), (2) the control diabetic group (D), (3) the high fat thermolyzed diet group (HFTD), which were fed a diet that was enriched in fat that was heated for 60 min at 180°C, (4) the high fat thermolyzed diet diabetic group (D + HFTD), (5) the high fat thermolyzed diet + Ω3 polyunsaturated fatty acid group (HFTD + Ω3), and (6) the high fat thermolyzed diet + Ω3 polyunsaturated fatty acid diabetic group (D + HFTD + Ω3). The most important finding of this study was that Ω3-PUFAs are able to reduce triglycerides, non-esterified fatty acid, lipoperoxidation levels, advanced glycation end products, SOD/CAT enzymatic ratio, and CAT immunocontent and increase SOD2 levels in the livers of diabetic rats fed with a HFTD. However, Ω3-PUFAs did not alter the observed levels of protein damage, blood glucose, or glycogen metabolism in the liver. These findings suggest that Ω3-PUFAs may represent an important auxiliary adjuvant in combating some diseases like diabetes mellitus, insulin resistance, and non-alcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989716     DOI: 10.1007/s11010-011-1099-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  55 in total

1.  Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells.

Authors:  B Smedsrød; J Melkko; N Araki; H Sano; S Horiuchi
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

2.  S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats.

Authors:  Ajit Vikram; Gopabandhu Jena
Journal:  Biochem Biophys Res Commun       Date:  2010-06-19       Impact factor: 3.575

3.  Liver glycogen accumulation in unstable diabetes.

Authors:  W G Manderson; M T McKiddie; D J Manners; J R Stark
Journal:  Diabetes       Date:  1968-01       Impact factor: 9.461

4.  Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status.

Authors:  Maite Figueras; Mireia Olivan; Sílvia Busquets; Francisco J López-Soriano; Josep M Argilés
Journal:  Obesity (Silver Spring)       Date:  2010-09-30       Impact factor: 5.002

5.  Circulating glycolaldehyde induces oxidative damage in the kidney of rats.

Authors:  Rodrigo Lorenzi; Michael Everton Andrades; Rafael Calixto Bortolin; Ryoji Nagai; Felipe Dal-Pizzol; José Cláudio Fonseca Moreira
Journal:  Diabetes Res Clin Pract       Date:  2010-06-03       Impact factor: 5.602

Review 6.  Advanced protein glycosylation in diabetes and aging.

Authors:  M Brownlee
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

Review 7.  Fatty acid regulation of gene transcription.

Authors:  Donald B Jump
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

8.  Monitoring of liver glycogen synthesis in diabetic patients using carbon-13 MR spectroscopy.

Authors:  Moyoko Tomiyasu; Takayuki Obata; Yukio Nishi; Hiromitsu Nakamoto; Hiroi Nonaka; Yukihisa Takayama; Joonas Autio; Hiroo Ikehira; Iwao Kanno
Journal:  Eur J Radiol       Date:  2008-12-05       Impact factor: 3.528

9.  Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose.

Authors:  Laura Toma; Camelia S Stancu; Gabriela M Botez; Anca V Sima; Maya Simionescu
Journal:  Biochem Biophys Res Commun       Date:  2009-10-20       Impact factor: 3.575

10.  Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis.

Authors:  Ayumi Sato; Hiroyuki Kawano; Tatsuto Notsu; Masahiko Ohta; Masanori Nakakuki; Kiyoshi Mizuguchi; Michiko Itoh; Takayoshi Suganami; Yoshihiro Ogawa
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

View more
  12 in total

1.  Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.

Authors:  Rafael Longhi; Roberto Farina Almeida; Letiane Machado; Maria Marta Medeiros Frescura Duarte; Débora Guerini Souza; Priscila Machado; Adriano Martimbianco de Assis; André Quincozes-Santos; Diogo Onofre Souza
Journal:  Eur J Nutr       Date:  2016-01-11       Impact factor: 5.614

2.  Linoleic and α-linolenic fatty acid consumption over three generations exert cumulative regulation of hepatic expression of genes related to lipid metabolism.

Authors:  Carolina B Jacometo; Eduardo Schmitt; Luiz F M Pfeifer; Augusto Schneider; Francielle Bado; Fernanda T da Rosa; Simone Halfen; Francisco A B Del Pino; Juan J Loor; Marcio N Corrêa; Nelson J L Dionello
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

3.  Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil.

Authors:  Claudio De Felice; Cinzia Signorini; Thierry Durand; Lucia Ciccoli; Silvia Leoncini; Maurizio D'Esposito; Stefania Filosa; Camille Oger; Alexandre Guy; Valérie Bultel-Poncé; Jean-Marie Galano; Alessandra Pecorelli; Laura De Felice; Giuseppe Valacchi; Joussef Hayek
Journal:  Genes Nutr       Date:  2012-03-08       Impact factor: 5.523

4.  Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients.

Authors:  Antonio Iannelli; Francesco Martini; Anne Sophie Schneck; Bijan Ghavami; Guillaume Baudin; Rodolphe Anty; Jean Gugenheim
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

5.  Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.

Authors:  Young-Eun Cho; Aninda Basu; Anzhi Dai; Michael Heldak; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

6.  Therapeutic effect of flax-based diets on fatty liver in aged laying hens.

Authors:  J E Davis; J Cain; C Small; D B Hales
Journal:  Poult Sci       Date:  2016-05-03       Impact factor: 3.352

Review 7.  Functional Meat Products as Oxidative Stress Modulators: A Review.

Authors:  Adrián Macho-González; Sara Bastida; Alba Garcimartín; María Elvira López-Oliva; Pilar González; Juana Benedí; María José González-Muñoz; Francisco J Sánchez-Muniz
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

8.  Cerebral Ketone Body Oxidation Is Facilitated by a High Fat Diet Enriched with Advanced Glycation End Products in Normal and Diabetic Rats.

Authors:  Adriano M de Assis; Jussemara S da Silva; Anderson Rech; Aline Longoni; Yasmine Nonose; Cendrine Repond; Matheus A de Bittencourt Pasquali; José C F Moreira; Diogo O Souza; Luc Pellerin
Journal:  Front Neurosci       Date:  2016-11-08       Impact factor: 4.677

9.  Novel regulatory roles of omega-3 fatty acids in metabolic pathways: a proteomics approach.

Authors:  Abeer A Ahmed; Kayode A Balogun; Natalia V Bykova; Sukhinder K Cheema
Journal:  Nutr Metab (Lond)       Date:  2014-01-17       Impact factor: 4.169

Review 10.  The Role of Oxidative Stress and Antioxidants in Liver Diseases.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Zhang-Jin Zhang; Lixing Lao; Chi-Woon Wong; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-11-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.